Comparison
Bacopa Monnieri vs Kanna
Bacopa Monnieri
Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. The active bacosides increase dendritic branching in the hippocampus over weeks of dosing. Effects are slow but durable; expect 8–12 weeks before full effect.
Kanna
Sceletium tortuosum — South African succulent. Acts as serotonin reuptake inhibitor and PDE4 inhibitor.
| Field | Bacopa Monnieri | Kanna |
|---|---|---|
| Category | adaptogen | adaptogen |
| Dose range | 300–600mg | 25–50mg |
| Half-life | 4h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●○○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 540 | 50 |
The comparison in plain English
Auto-generated from dataBacopa Monnieri and Kanna are both in the adaptogen category respectively. Bacopa Monnieri Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. Kanna Sceletium tortuosum — South African succulent.
Bottom line
Bacopa Monnieri (evidence A, safety 5/5) has a weaker evidence base than Kanna (evidence B, safety 3/5). Bacopa Monnieri has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Bacopa Monnieri if
Bacopa Monnieri is the better fit when your goal aligns with its mechanism (Active bacosides A and B increase dendritic branching in the CA3 region of the hippocampus, the structural change that underlies improved memory consolidation) and the dose range (300–600mg) suits your protocol. Half-life is 4h.
Choose Kanna if
Kanna is the better fit when your goal aligns with its mechanism (Mesembrine and related alkaloids inhibit serotonin reuptake (similar to SSRI mechanism but at much lower potency) and PDE4 (similar to rolipram)) and the dose range (25–50mg) suits your protocol. Half-life is —h.